Company Overview of Diatide, Inc.
As of October 22, 1999, Diatide, Inc. was acquired by Schering Berlin, Inc. Diatide, Inc. is a development stage specialty pharmaceutical company engaged in the discovery, development, and commercialization of patented, disease-specific imaging agents, and therapeutics drugs for life-threatening diseases and conditions. The company is headquartered at Londonderry, New Hampshire.
Nine Delta Drive
Londonderry, NH 03053
Key Executives for Diatide, Inc.
Diatide, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Synthrx, Inc.||United States|
|Meda Pharmaceuticals, Inc.||United States|
|NeuroGenomeX, Inc.||United States|
|Avidia, Inc.||United States|
|Cystic Fibrosis Foundation Therapeutics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
To contact Diatide, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.